Navigation Links
Open Letter to President-Elect Barack Obama From Don Margolis, Chairman and Founder of The Repair Stem Cell Institute
Date:11/24/2008

    WASHINGTON, Nov. 24 /PRNewswire-USNewswire/ --

    Dear President-Elect Obama:

Your first four year Presidential term will start with billions of dollars earmarked for stem cell research. As spokesman for the Repair Stem Cell Institute (RSCI), which is the voice of the Repair Stem Cell research and treatment industry worldwide, I want to urge you to provide equal federal funding support for our industry and the medical and scientific professionals, hospitals, treatment centers and academic leaders that are, today, actively applying their stem cell expertise in improving the lives of people suffering with various diseases.

What does the phrase "Repair Stem Cell" mean? And how is this stem cell life science helping to improve the lives of people around the world?

All of our bodies already contain a cell that "repairs" our bodies and performs this function every day of our lives. It's called the Repair Stem Cell. These cells constantly jump to our aid when we need help. Cut your finger, no problem a Repair Stem Cell will do its work and heal your skin. Injure another part of your body and Repair Stem Cells are always ready to jump in and help. Sometimes, though, our bodies need help to muster more of these Repair Stem Cells to our aid than our bodies normally provide. That's when we need the help of medical science to supplement our bodies' own tool- kit.

As the future 44th President of the United States this January '09, I urge you to review the scientific and medical advances of Repair Stem Cells. For example, Osiris, a U.S. company using Repair Stem Cell science, has a product that is being evaluated in Phase III clinical trials for three indications, including acute and steroid refractory Graft versus Host Disease and also Crohn's disease, and is currently designated by the FDA as both an Orphan Drug and Fast Track product. Bioheart, another U.S. company, is also in phase II/III clinical trials seeking to improve the lives of heart failure patients with active trials in 35 leading centers in the U.S. and 19 overseas using its own unique Repair Stem Cell technology. Cytori Therapeutics in California is already using its special devices and new Repair Stem Cell technology in Europe and soon in the U.S. to help reconstruct breast tissue in cancer survivors who have undergone partial mastectomy.

The Repair Stem Cell Institute and its members worldwide need your support in making sure that the advances already achieved by Repair Stem Cell life science continue into the future. Millions of people suffering from diabetes, heart disease, kidney disease, spinal cord injury and many other medical conditions are looking to you for leadership on stem cell policy. I call upon you now to include Repair Stem Cell research in all forthcoming federal funding programs in 2009 and beyond.

The Repair Stem Cell Institute and its members pledge to you, Mr. President-Elect, its total cooperation in helping all Americans enjoy the benefits of Repair Stem Cell science in the years ahead.

    Sincerely,
    Don Margolis
    Chairman and Founder
    Repair Stem Cell Institute (RSCI)
    www.RepairStemCells.org

About RSCI: The Repair Stem Cell Institute (RSCI; www.RepairStemCells.org) is an international public service company dedicated to educating and informing the public about Repair Stem Cell research and treatments. RSCI was formed in April 2008 and has offices in Dallas, Texas, Washington, D.C. and Bangkok, Thailand.


'/>"/>
SOURCE The Repair Stem Cell Institute
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Abbott Receives Complete Response Letter From FDA for Controlled-Release Hydrocodone With Acetaminophen
2. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
3. September 2008 Mayo Clinic Health Letter Highlights Cataract Removal, Severe Headache and Dual Energy X-Ray Imaging
4. U.S. FDA Issues Action Letter for Sugammadex
5. Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
6. Wyeth Receives Approvable Letter From FDA for Bazedoxifene for the Treatment of Postmenopausal Osteoporosis
7. Strykers Biotech Division Receives FDA Warning Letter
8. An Open Letter to Parents, Students, School Administrators, & Health Care Officials from Soapopular(R)
9. For Most, Good Oral Care Does More Than Antibiotics to Prevent Dental-Related Heart Problems, Reports the Harvard Heart Letter
10. CEL-SCI Corporation Releases Letter to Shareholders
11. Tone Deafness Explained, from the Harvard Health Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)...  AllianceRx Walgreens Prime, the combined central specialty pharmacy ... benefit manager Prime Therapeutics LLC (Prime), today officially began ... unveiling of new signage at its headquarters in ... a few other company-owned facilities across the country. This ... of whom will begin to see the AllianceRx Walgreens ...
(Date:9/27/2017)... their devotion to personalized service, SMP Pharmacy Solutions announces their ... South Florida Business Journal,s 50 Fastest-Growing Companies, and listed for ... specialty pharmacy has found its niche.  To that end, the ... by SFBJ as the 2017 Power Leader in Health Care. ... award in October, Bardisa said of the three achievements, "It,s ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ... the introduction of an innovative new design of the shoulder pad. The shoulder ... maximum comfort while controlling your pain while using cold therapy. By utilizing ice and ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information ... we intend to develop to enable prevention of a major side effect of ... loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the University of California Berkeley, and other leading institutions in announcing the launch ... of institutions to change the way animals are raised for food. , Founding ...
Breaking Medicine News(10 mins):